Références

  1. National Women's Health Resource Center. Survey of women who experience heavy menstrual bleeding. Data on file; 2005.
  2. Cooper J, et al. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9:418-428.
  3. Istre O, et al. Treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Fertil Steril 2001;76:304-309.
  4. Hurskainen R, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456-1463.
  5. DeCherney AH, et al. Current Obstetric & Gynecologic Diagnosis & Treatment, Ninth edition. New York, NY: McGraw-Hill Medical; 2003.
  6. . Cooper KG, et al. A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss. Br J Obstet Gynaecol 1997;104:1360-1366.
  7. Singh RH, et al. Hormonal management of abnormal uterine bleeding. Clin Obstet Gynecol 2005;48:337-352.
  8. Siddle N, et al. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47:94-100.
  9. "Quality of life at 1 year" table, NovaSure [Instructions for Use]. Bedford, MA, USA: Hologic, Inc.; 2011
  10. NovaSure [Instructions for Use]. Bedford, MA, USA: Hologic, Inc.; 2011